Case Study: Parexel® Medical Imaging Supports AbbVie’s Elagolix

July 20, 2020

Recently, Parexel supported a Phase III study of AbbVie’s Elagolix, a uterine fibroid treatment, that incorporated four complex medical imaging modalities utilized by investigative sites.

Previous Article
The Future Is Now: Decentralized Clinical Trials During the Pandemic and Beyond
The Future Is Now: Decentralized Clinical Trials During the Pandemic and Beyond

Decentralized clinical trials (DCT) had already begun to gain momentum, and the pandemic has dramatically a...

Next Article
FSP and COVID-19: Impact on Clinical Trial Development
FSP and COVID-19: Impact on Clinical Trial Development

The functional service provider (FSP) outsourcing model enables sponsors to efficiently and cost-effectivel...